DEEPER INSIGHTS, MULTIMODAL DRUGS
We translate genomic intelligence into multi-targeting therapies
THE PARADIGM SHIFT
MULTIMODAL DRUGS TO IMPROVE OUTCOMES AND COMBAT DRUG RESISTANCE

Oligon™ is developing a new class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance. Our proprietary SeekR™ platform is used to digitally engineer and rapidly produce self-delivering therapeutics which target specific tissues with unprecedented precision and accuracy. We are focused on building a pipeline of products in oncology, yet our multimodal RNA platform can be harnessed to transform outcomes for any complex multigenic disease.

transformative rna therapeutics platform

Oligon™ is an emerging biotechnology company developing a novel class of multimodal RNA therapeutics.

Oligon's patent protected SeekR™ RNA therapeutic platform technology connects dual RNA aptamer BINDERS flanking a double stranded RNA bridge that encodes for 2 or more siRNA SILENCERS. The BINDER and SILENCER components are selected, created and integrated together into a single chimeric RNA oligonucleotide agent which can be chemically synthesized and efficiently manufactured on scale.

A SeekR™ is a single self-delivering RNA compound that can be designed and directed to seek out receptors on specific cell type or tissues with unprecedented precision and accuracy.

Multiple in vivo studies have demonstrated that Oligon’s SeekR™ therapeutic agents are pharmacologically stable, well tolerated and highly effective against various animal models of cancer.

The Company has a robust pipeline of novel pre-clinical cancer programs and expects to initiate the first IND-enabling studies soon.

Oligon™ has the potential to transform the RNA therapeutics field, and to eventually disrupt the antibody therapeutics industry.

Core Values
IMAGINATION
INNOVATION
INTEGRITY
Contact Oligon
7201 E. Henkel Way, Suite 205, Scottsdale, AZ 85255
cvillani@oligon.com
STEP 1
STEP 2
STEP 3
Leadership
Industry innovators with deep experience
Spyro Mousses, PHD
Spyro Mousses, PHD
Spyro Mousses, PHD
Contact Oligon
7201 E. Henkel Way, Suite 205, Scottsdale, AZ 85255
info@oligon.com
©COPYRIGHT 2021 Oligon Inc. ALL RIGHTS RESERVED.